Get the Stockscreener App
4.435
2.42%
0.105
Omniab Inc stock is traded at $4.435, with a volume of 130.36K.
It is up +2.42% in the last 24 hours and up +11.15% over the past month.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
See More
Previous Close:
$4.33
Open:
$4.31
24h Volume:
130.36K
Relative Volume:
0.35
Market Cap:
$518.73M
Revenue:
$34.16M
Net Income/Loss:
$-50.62M
P/E Ratio:
-27.81
EPS:
-0.1595
Net Cash Flow:
$703.00K
1W Performance:
+12.56%
1M Performance:
+11.15%
6M Performance:
-5.03%
1Y Performance:
-5.64%
1-Day Range:
$4.30
$4.435
1-Week Range:
$3.855
$4.435
52-Week Range:
$3.56
$6.715
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
OmniAb (OABI) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Rice Hall James & Associates LLC Raises Stake in OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
OmniAb to Participate in Two Investor Conferences in November - StockTitan
Bleakley Financial Group LLC Trims Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb to Report Third Quarter 2024 Financial Results on November 12 - StockTitan
The Manufacturers Life Insurance Company Invests $147,000 in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth? - Yahoo Finance
Millennium Management LLC Reduces Stock Position in OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
Sei Investments Co. Has $109,000 Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Dimensional Fund Advisors LP Buys 194,835 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
American Century Companies Inc. Raises Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb's SWOT analysis: antibody discovery firm's stock faces pivotal 2H24 - Investing.com
OmniAb's SWOT analysis: antibody discovery firm's stock faces pivotal 2H24 By Investing.com - Investing.com UK
The Attractiveness of Investing In OmniAb Inc (OABI) is Growing - Knox Daily
OmniAb (NASDAQ:OABI) & Starpharma (OTCMKTS:SPHRY) Critical Review - Defense World
OmniAb (NASDAQ:OABI) Trading Down 5.5% - MarketBeat
OmniAb (NASDAQ:OABI) Shares Down 5.5% - Defense World
Checking in on OmniAb Inc (OABI) after recent insiders movement - Knox Daily
Is OmniAb Inc (OABI) positioned for future growth? - SETE News
A Guide To The Risks Of Investing In OmniAb Inc (OABI) - Knox Daily
Are OmniAb Inc’shares a good deal? - US Post News
A better buy-in window may exist right now for OmniAb Inc (OABI) - SETE News
OmniAb Inc [OABI] Investment Guide: What You Need to Know - Knox Daily
Isthmus Partners LLC Buys 143,387 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
Allspring Global Investments Holdings LLC Has $284,000 Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Ratios Uncovered: Breaking Down OmniAb Inc (OABI)’s Trailing Twelve Months Metrics - The Dwinnex
Was anything positive for OmniAb Inc (OABI) stock last session? - US Post News
Kornitzer Capital Management Inc. KS Sells 274,985 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
OmniAb Inc [OABI] Records 200-Day SMA of $4.95 - Knox Daily
Analyzing the Impact of Earnings Reports on OmniAb Inc Inc. (OABI) Price Performance - The InvestChronicle
SG Americas Securities LLC Has $64,000 Stock Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Is it possible to buy OmniAb Inc(OABI) shares at a good price now? - US Post News
How To Buy OmniAb, Inc. Stock Online in August 2024 - Traders Union
OmniAb to Participate in Two Investor Conferences in September - StockTitan
OmniAb (NASDAQ:OABI) Given “Buy” Rating at Benchmark - Defense World
OmniAb (NASDAQ:OABI) Rating Reiterated by Benchmark - MarketBeat
Investing in OmniAb Inc (OABI): What You Must Know - Knox Daily
There is no way OmniAb Inc (OABI) can keep these numbers up - SETE News
OmniAb, Inc. (NASDAQ:OABI) Shares Sold by California State Teachers Retirement System - Defense World
OmniAb (NASDAQ:OABI) Rating Reiterated by Royal Bank of Canada - Defense World
Price T Rowe Associates Inc. MD Buys 3,108 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb's (OABI) Outperform Rating Reiterated at Royal Bank of Canada - MarketBeat
Earnings call: OmniAb reports growth and solid Q2 financials - Investing.com
Simplicity Wealth LLC Buys 7,976 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb (NASDAQ:OABI) Earns Buy Rating from HC Wainwright - MarketBeat
It is Poised to be a Bull Market for OmniAb Inc (OABI) - SETE News
OmniAb (NASDAQ:OABI) Receives “Buy” Rating from HC Wainwright - Defense World
OmniAb, Inc. (NASDAQ:OABI) Q2 2024 Earnings Call Transcript - Insider Monkey
OmniAb (NASDAQ:OABI) Shares Gap Up to $4.29 - Defense World
OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript - Seeking Alpha
OmniAb Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omniab Inc Stock (OABI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FOEHR MATTHEW W | President and CEO |
Jun 27 '24 |
Option Exercise |
3.73 |
59,659 |
222,416 |
3,599,166 |
| FOEHR MATTHEW W | President and CEO |
May 24 '24 |
Buy |
4.42 |
240,000 |
1,059,840 |
3,536,665 |
| GUSTAFSON KURT A | Executive VP, Finance and CFO |
Apr 08 '24 |
Sale |
5.27 |
6,954 |
36,648 |
176,697 |
| Berkman Charles S | Chief Legal Officer |
Apr 08 '24 |
Sale |
5.27 |
6,954 |
36,648 |
292,617 |
| GUSTAFSON KURT A | Executive VP, Finance & CFO |
Apr 01 '24 |
Sale |
5.46 |
11,849 |
64,696 |
170,110 |
| FOEHR MATTHEW W | President and CEO |
Mar 27 '24 |
Option Exercise |
3.72 |
243,613 |
907,023 |
3,152,416 |
| FOEHR MATTHEW W | President and CEO |
Mar 22 '24 |
Buy |
5.19 |
225,000 |
1,167,750 |
2,908,803 |
| FOEHR MATTHEW W | Chief Executive Officer |
Dec 12 '23 |
Buy |
5.05 |
200,000 |
1,010,000 |
2,645,442 |
| FOEHR MATTHEW W | President and CEO |
Nov 10 '23 |
Buy |
4.27 |
95,000 |
405,517 |
2,427,919 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):